Search

everythinglearnresearchcommunity

for

Search:↓

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Physical activity, height, and smoking affect prostate cancer risk.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Human hair protein modifications could potentially indicate heart disease risk.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Multi-pass laser skin treatments improved healing, reduced pain, and had no major complications.

Hair conditions can be linked to diabetes and affect psychological health.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Hair product allergies are common, especially to hair dyes, and hairdressers are at higher risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.